Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

On the road to ending the COVID-19 pandemic: Are we there yet?

Virology(2021)10.1016/j.virol.2021.02.003Source: DataRank Database

On the road to ending the COVID-19 pandemic: Are we there yet? is a research paper published in Virology (2021). On theSindex it has a DataRank of 0. It has been cited 53 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access53 citations

Download PDF

Cite:

Linked data & code

nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 3.16)OA: bronzeTopics (88)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Emma S. Winkler ORCID,John M. Errico ORCID,Michael Diamond ORCID,James Brett Case ORCID

Live enrichment

PubMed:33676349 PMC:PMC7908885 OpenAlex:https://openalex.org/W3135353939

NIAID NIH HHS

Grant: F30 AI152327

NIAID NIH HHS

Grant: R01 AI157155

National Institutes of Health

Grant: 1F30AI152327-01A1

Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut Microbiota

National Institutes of Health

Grant: 5R01AI157155-02

Human antibody-based countermeasures against the Coronavirus SARS-CoV-2

DARPA

National Institutes of Health

FWCI

3.16

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttps://www.sciencedirect.com/science/article/pii/S0042682221000374/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S0042682221000374/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0042682221000374?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0042682221000374?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.virol.2021.02.003

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing0301 basic medicine03 medical and health sciencesAnimalsAntibodies, ViralCOVID-19COVID-19 VaccinesClinical Trials as TopicDisease Models, AnimalGenetic VectorsHumansImmunity, InnateImmunization, PassiveImmunogenicity, VaccinePandemicsPatient SafetySARS-CoV-2Vaccines, AttenuatedVaccines, DNAVaccines, SubunitVaccines, Virus-Like ParticleCOVID-19 Serotherapy

MeSH Terms

Immunogenicity, VaccineCOVID-19SARS-CoV-2COVID-19 VaccinesCOVID-19 SerotherapyAnimalsAntibodies, ViralClinical Trials as TopicDisease Models, AnimalGenetic VectorsHumansImmunity, InnateImmunization, PassiveVaccines, AttenuatedVaccines, DNAVaccines, SubunitVaccines, Virus-Like ParticlePandemicsPatient Safety

Keywords

PandemicCoronavirus disease 2019 (COVID-19)PaceDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyPopulation2019-20 coronavirus outbreakPublic healthCoronavirusVirologyDevelopment economicsOutbreakEconomic growthEnvironmental healthInfectious disease (medical specialty)MedicineGeographyEconomicsVaccinesProtectionAntibodyTherapyImmunityPathogenesisCovid-19Sars-cov-2Clinical Trials as TopicCOVID-19 VaccinesGenetic VectorsImmunization, PassiveAntibodies, ViralVaccines, AttenuatedArticleImmunity, InnateDisease Models, AnimalImmunogenicity, VaccineVaccines, SubunitVaccines, DNAAnimalsHumansPatient SafetyVaccines, Virus-Like ParticlePandemicsCOVID-19 Serotherapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

On the road to ending the COVID-19 pandemic: Are we there yet?

FAIR Checklist

Authors (4)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)